V
Vigil Neuro
0 followers
Vigil Neuroscience is the world’s first microglia-focused therapeutics company. Their purpose is clear: to treat rare and common neurodegenerative diseases by restoring the vigilance of the microglia, the sentinel cells of the brain’s immune system. They are utilizing the tools of modern neuroscienc... Read more
Org chart
Ivana Magovčević-Liebisch
President & CEO
Ivana Magovčević-Liebisch
Collapse
Andreas Meier
SVP, Clinical & Medical Sciences
Evan Thackaberry
SVP & Head, Early Development
Weeteck Yeo
SVP, Strategic Operations
Jessica Stromme
SVP, Program Leadership & Portfolio Management
Jonathan Houze
VP, Small Molecule Discovery
Christian Mirescu
VP & Head, Neuroimmunology
Cynthia Cassandro
VP, Patient Advocacy & Engagement
Kevin Durfee
VP & Head, Information Technology
Elizabeth Thompson
Senior Director, Biometrics
Dwayne Stanley
Senior Director, Program Management
Evangelia Hatzis
Senior Director, Program Management
Sharon Morani
Senior Director, Facilities & Operations
Meghan Pagliarini
Executive Liaison to the President & CEO
Jane Lydon
Executive Assistant
Julia Keefe
Associate Director, Investor Relations & Corporate Communications
Leah Gibson
VP, Investor Relations & Corporate Communications
Michael Cohen
Associate General Counsel
Rizwan Manzer
Director, CMC & Technical Operations
Board & advisors
Bruce Booth
Chairman
Gerhard Koenig
Director
Cheryl Blanchard
Director
Stefan Vitorovic
Director
Mary Thistle
Director
Suzanne Bruhn
Director
Marco Colonna
Chairman, Scientific Advisory Board
Bradley Hyman
Scientific Advisor
Jaime Grutzendler
Scientific Advisor
John Dunlop
Scientific Advisor
Ole Isacson
Scientific Advisor
Samantha Budd Haeberlein
Director